Introduction

The Canadian Cancer Research Alliance (CCRA) is an alliance of organizations that collectively fund most of the cancer research conducted in Canada – research that will lead to:

  • better ways to prevent cancer
  • diagnose cancer
  • treat cancer and
  • improve patient and survivor outcomes.

Members include federal research funding programs/agencies, provincial research agencies, provincial cancer care agencies, cancer charities, and other voluntary associations. 

We are motivated by the belief that, through effective collaboration, Canadian cancer research funding organizations can maximize their collective impact on cancer control and accelerate discovery for the ultimate benefit of Canadians affected by cancer.

Our Executive Office is supported by the Canadian Partnership Against Cancer, an independent, not-for-profit organization funded by the federal government to accelerate action on cancer control for all Canadians. For more information on the Partnership’s role, click here.

The CCRA is not a registered charity and cannot accept donations. If you wish to donate to a charity that funds cancer research, please check our Members page.

CCRA... 

  • has been publishing reports on the annual investment in cancer research in Canada since 2007 (to access, click here)
  • also publishes research investment reports on childhood and adolescent cancers, cancer risk and prevention, early translation, survivorship, and palliative and end-of-life care (to access, click here)
  • has developed two pan-Canadian cancer research strategies, which identify key priorities for cancer research funding collaboration (to access, click here)
  • has produced specific research frameworks for prevention, survivorship, and palliative and end-of-life care, as well as a report on the state of cancer clinical trials in Canada (to access, click here)
  • CCRA’s publications have been cited in more than 50 scientific papers (for a listing of these papers, click here)
  • has convened three scientific conferences, with the fourth scheduled for November 2017 in Vancouver (for more information, click here)
  • recognizes, on a biennial basis, the accomplishments of key leaders in cancer research (for more information, click here).

Please enter the email address for your account. A verification code will be sent to you. Once you have received the verification code, you will be able to choose a new password for your account.

Other News and Events...

New Logo, New Look

The Terry Fox Research Institute introduced a new logo and launched a new website to reflect the innovative nature of its research. Check it out! In addition, the 2019 Federal Budget included an investment of up to $150M over the next five years for the Marathon of Hope Cancer Centres network. The network will be officially launched on April 12, 2019 in St. John's -- the same day and place where Terry began his Marathon of Hope 39 years ago. For more, see https://www.tfri.ca/our-research/marathon-of-hope

BioCanRx Targeted Funding - Cycle II

BioCanRx, Canada’s Immunotherapy Network, is pleased to announce its 2019 Call for Letters of Intent. Selected Letters of Intent will be featured in the Scientific Program of its Cycle II application going forward for review in July 2019 to the federal government’s Networks of Centres of Excellence (NCE) Program.

Building on previous BioCanRx investments in Cycle I, the overarching goal of the Cycle II Research Program will focus on extending immunotherapy successes in the clinic beyond initial responders. To address this challenge, while making use of technologies in the BioCanRx pipeline or by soliciting new complimentary technology, BioCanRx will invest in projects aimed at understanding patient and/or tumour type limitation(s) and proposing improved novel therapies, trials, or combination approaches to overcome the identified limitation(s)

Applications must be received by Wednesday, May 1, 2019. Full details here.